Benralizumab can be used for the treatment of acute eosinophilic exacerbations of asthma and chronic obstructive pulmonary ...

Summary. Exacerbations of COPD are common and can be detrimental to both patient health and health care costs. Corticosteroids are recommended by consensus guidelines for patients during ...

Benralizumab can be used for the treatment of acute eosinophilic exacerbations of asthma and chronic obstructive pulmonary ...

This is attributed to increased systemic inflammation. The course of COPD is punctuated by exacerbations, which further increase systemic inflammation, but the risk of vascular events in the ...

Patients with COPD who have mucus plugs identified via CT scans are associated with greater risks for acute exacerbations of their disease.

A dipstick urine test and a mobile app may help predict disease exacerbations in COPD patients as much as a week in advance, ...

A new study found that the C-reactive protein point-of-care test (CRP-POCT) is a low-cost technique for safely lowering ...

Background Exacerbations of chronic obstructive pulmonary disease (COPD) are characterised by increased dyspnoea, reduced quality of life and muscle weakness. Re-exacerbation and hospital admission ...

A careful economic analysis is required to determine the cost-effectiveness of a biologic treatment strategy in the management of exacerbations. Third, while the investigators argue for a so-called ...

No fatal adverse events occurred, and benralizumab was well tolerated. HealthDay News — Benralizumab can be used for the treatment of acute eosinophilic exacerbations of asthma and chronic obstructive ...

TUESDAY, Dec. 10, 2024 (HealthDay News) -- Benralizumab can be used for the treatment of acute eosinophilic exacerbations of asthma and chronic obstructive pulmonary disease (COPD), according to a ...